We are live on ! Find out more
HP

Harbourvest Partners Portfolio holdings

AUM $101M
1-Year Est. Return 38.13%
This Fund
S&P 500
This Quarter Est. Return
-18.81%
1 Year Est. Return
-38.13%
3 Year Est. Return
-6.18%
5 Year Est. Return
-50.73%
10 Year Est. Return
+34.53%
AUM
$782M
AUM Growth
-$282M
Cap. Flow
-$84.9M
Cap. Flow %
-10.86%
Top 10 Hldgs %
83.65%
Holding
79
New
23
Increased
7
Reduced
7
Closed
12

Top Buys

Rank Stock Value
1
TOST icon
Toast
TOST
+$125M
2
AMPL icon
Amplitude
AMPL
+$9.65M
3
BE icon
Bloom Energy
BE
+$5.62M
4
U icon
Unity
U
+$4.47M
5
SPOT icon
Spotify
SPOT
+$4.19M

Top Sells

Rank Stock Value
1
MNDY icon
monday.com
MNDY
+$221M
2
WHD icon
Cactus
WHD
+$14.8M
3
WRBY icon
Warby Parker
WRBY
+$8.14M
4
NET icon
Cloudflare
NET
+$7.32M
5
PATH icon
UiPath
PATH
+$3.97M

Sector Composition

Rank Sector Weight
1 Technology 49.91%
2 Consumer Discretionary 26.48%
3 Healthcare 14.01%
4 Communication Services 4.05%
5 Industrials 2.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MCRB icon
51
Seres Therapeutics
MCRB
$45M
$411K 0.05%
2,468
METC icon
52
Ramaco Resources Class A
METC
$629M
$401K 0.05%
+30,471
New +$396K
DASH icon
53
DoorDash
DASH
$84.3B
$373K 0.05%
+2,505
New +$474K
CTMX icon
54
CytomX Therapeutics
CTMX
$690M
$343K 0.04%
79,193
LOV
55
DELISTED
Spark Networks SE American Depositary Shares
LOV
$327K 0.04%
104,228
-396,798
-79% -$1.17M
PMVP icon
56
PMV Pharmaceuticals
PMVP
$57.1M
$266K 0.03%
11,533
+3,841
+50% +$92.8K
RPTX
57
DELISTED
Repare Therapeutics
RPTX
$259K 0.03%
12,276
BLND icon
58
Blend Labs
BLND
$438M
$243K 0.03%
+33,128
New +$384K
IPSC icon
59
Century Therapeutics
IPSC
$364M
$232K 0.03%
+14,631
New +$275K
OYST
60
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
$229K 0.03%
12,560
DAWN
61
DELISTED
Day One Biopharmaceuticals
DAWN
$226K 0.03%
+13,388
New +$275K
ALGS icon
62
Aligos Therapeutics
ALGS
$26.3M
$223K 0.03%
751
CVRX icon
63
CVRx
CVRX
$131M
$66K 0.01%
5,396
-208,083
-97% -$3.02M
KA
64
DELISTED
Kineta, Inc. Common Stock
KA
$65K 0.01%
3,147
EPZM
65
DELISTED
Epizyme, Inc
EPZM
$62K 0.01%
24,686
NXTC icon
66
NextCure
NXTC
$20.4M
$60K 0.01%
837
TRVN
67
DELISTED
Trevena, Inc.
TRVN
$37K ﹤0.01%
101
-273
-73% -$151K
ARVN icon
68
Arvinas
ARVN
$530M
-21,111
Closed -$1.74M
CRWD icon
69
CrowdStrike
CRWD
$183B
-44,336
Closed -$2.72M
DELL icon
70
Dell
DELL
$239B
-9,960
Closed -$525K
NET icon
71
Cloudflare
NET
$96B
-65,004
Closed -$7.32M
NRIX icon
72
Nurix Therapeutics
NRIX
$2.45B
-39,762
Closed -$1.19M
OKTA icon
73
Okta
OKTA
$23.8B
-12,697
Closed -$3.01M
PUBM icon
74
PubMatic
PUBM
$608M
-54,505
Closed -$1.44M
SNDX icon
75
Syndax Pharmaceuticals
SNDX
$1.7B
-28,498
Closed -$545K

Similar funds

Harbourvest Partners's Q4 2021 Portfolio in Review

As of Q4 2021, Harbourvest Partners held 79 positions worth $782M, down 27% from $1.06B the previous quarter. Its ten largest holdings account for 84% of the portfolio.

Harbourvest Partners withdrew a net $84.9M in Q4 2021, closing 12 positions and reducing 7 holdings. Its most notable exit was Cactus, an estimated $14.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 50% of assets, down from 50% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Harbourvest Partners opened a new position in Toast worth $94.1M.

  • Harbourvest Partners's largest Q4 2021 buy was Toast: 2,709,610 shares worth $94.1M.
  • Harbourvest Partners added most to Unity in Q4 2021, an estimated $4.47M increase.
  • Harbourvest Partners's biggest Q4 2021 reduction was monday.com, cutting an estimated $221M.
  • Harbourvest Partners fully exited Cactus in Q4 2021, selling an estimated $14.8M.
  • Harbourvest Partners's ten largest holdings make up 84% of its $782M portfolio in Q4 2021.
  • Harbourvest Partners opened 23 new positions and closed 12 in Q4 2021.
  • Harbourvest Partners's portfolio value fell 27% quarter-over-quarter to $782M.

Based on Harbourvest Partners's 13F filing for Q4 2021, filed 14 Feb 2022.